ITCI Annual Short Term Debt
$3.61 M
-$955.00 K-20.91%
31 December 2023
Summary:
As of January 21, 2025, ITCI annual short term debt is $3.61 million, with the most recent change of -$955.00 thousand (-20.91%) on December 31, 2023. During the last 3 years, it has fallen by -$1.93 million (-34.82%). ITCI annual short term debt is now -46.35% below its all-time high of $6.73 million, reached on December 31, 2021.ITCI Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Quarterly Short Term Debt
$4.20 M
+$32.00 K+0.77%
30 September 2024
Summary:
As of January 21, 2025, ITCI quarterly short term debt is $4.20 million, with the most recent change of +$32.00 thousand (+0.77%) on September 30, 2024. Over the past year, it has increased by +$619.00 thousand (+17.27%). ITCI quarterly short term debt is now -96.64% below its all-time high of $125.00 million, reached on September 30, 2016.ITCI Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.9% | +17.3% |
| 3 y3 years | -34.8% | +17.3% |
| 5 y5 years | +100.0% | +17.3% |
ITCI Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.4% | at low | -45.7% | +19.0% |
| 5 y | 5-year | -46.4% | +13.3% | -45.7% | +31.9% |
| alltime | all time | -46.4% | -96.6% |
Intra-Cellular Therapies Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.20 M(+0.8%) |
| June 2024 | - | $4.17 M(+14.6%) |
| Mar 2024 | - | $3.64 M(+0.7%) |
| Dec 2023 | $3.61 M(-20.9%) | $3.61 M(+0.8%) |
| Sept 2023 | - | $3.58 M(+0.7%) |
| June 2023 | - | $3.56 M(+0.8%) |
| Mar 2023 | - | $3.53 M(-22.7%) |
| Dec 2022 | $4.57 M(-32.2%) | $4.57 M(-37.0%) |
| Sept 2022 | - | $7.25 M(-6.4%) |
| June 2022 | - | $7.74 M(+1.4%) |
| Mar 2022 | - | $7.64 M(+13.4%) |
| Dec 2021 | $6.73 M | $6.73 M(+10.7%) |
| Sept 2021 | - | $6.08 M(+8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $5.60 M(+0.4%) |
| Mar 2021 | - | $5.57 M(+0.6%) |
| Dec 2020 | $5.54 M(+73.9%) | $5.54 M(+5.2%) |
| Sept 2020 | - | $5.27 M(+32.5%) |
| June 2020 | - | $3.97 M(+23.8%) |
| Mar 2020 | - | $3.21 M(+0.7%) |
| Dec 2019 | $3.19 M(>+9900.0%) | $3.19 M(+39.4%) |
| Sept 2019 | - | $2.29 M(+1.1%) |
| June 2019 | - | $2.26 M(-21.2%) |
| Mar 2019 | - | $2.87 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00(-100.0%) |
| Sept 2016 | - | $125.00 M(>+9900.0%) |
| June 2013 | - | $9300.00 |
FAQ
- What is Intra-Cellular Therapies annual short term debt?
- What is the all time high annual short term debt for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual short term debt year-on-year change?
- What is Intra-Cellular Therapies quarterly short term debt?
- What is the all time high quarterly short term debt for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly short term debt year-on-year change?
What is Intra-Cellular Therapies annual short term debt?
The current annual short term debt of ITCI is $3.61 M
What is the all time high annual short term debt for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual short term debt is $6.73 M
What is Intra-Cellular Therapies annual short term debt year-on-year change?
Over the past year, ITCI annual short term debt has changed by -$955.00 K (-20.91%)
What is Intra-Cellular Therapies quarterly short term debt?
The current quarterly short term debt of ITCI is $4.20 M
What is the all time high quarterly short term debt for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly short term debt is $125.00 M
What is Intra-Cellular Therapies quarterly short term debt year-on-year change?
Over the past year, ITCI quarterly short term debt has changed by +$619.00 K (+17.27%)